Some of the residues in this disordered region have been demonstrated to interact with WW domains (72), and clinical studies have reported leukemia patients with quite a few mutations in this region (17); future studies will be required to elucidate how the middle region works together with the FERM and PTP domains to carry out its function. The gene discussed is PTPRU; the disease is leukemia.